| Name | Title | Contact Details |
|---|
Peoples Health is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders. Through its medical solutions, Braxia aims to reduce the illness burden of brain-based disorders, such as major depressive disorder among others. Braxia is primarily focused on (i) owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and (ii) research activities related to discovering and commercializing novel drugs and delivery methods. Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. Through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., Braxia currently operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Kitchener-Waterloo, Ottawa, and Montreal.
HealthEast Care System is a community-focused, nonprofit healthcare system that provides a full spectrum of HealthEast Care System is a community-focused, nonprofit healthcare system that provides a full spectrum of family health services. Hospitals include St. Joseph`s Hospital, St. John`s Hospital, Woodwinds Health Campus and Bethesda Rehabilitation Hospital. Other services include hospitals, physician clinics, senior care centers, rehabilitation facilities, hospice, home care, outpatient surgery centers, and a variety of other health facilities and programs. HealthEast has approximately 7,500 employees and has more than 1,300 physicians on staff. Locally owned and operated, HealthEast is the largest health care provider in the Twin Cities` East Metro area.
StaffDNA gives healthcare professionals complete career control for higher-paying opportunities and flexibility. Search the highest-paying travel nurse and allied health jobs in the country, no registration required.
Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.